Debra Stultz, MD - Medicare Psychiatry in Barboursville, WV

Debra Stultz, MD is a medicare enrolled "Psychiatry & Neurology - Psychiatry" physician in Barboursville, West Virginia. She went to Jc Edwards School Of Medicine, Marshall University and graduated in 1989 and has 35 years of diverse experience with area of expertise as Psychiatry. She is a member of the group practice Stultz Sleep Study Services, Pllc and her current practice location is 6171 Childers Rd, Barboursville, West Virginia. You can reach out to her office (for appointments etc.) via phone at (304) 733-5380.

Debra Stultz is licensed to practice in West Virginia (license number 16672) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1346249836.

Contact Information

Debra Stultz, MD
6171 Childers Rd,
Barboursville, WV 25504-1227
(304) 733-5380
(304) 733-5796



Physician's Profile

Full NameDebra Stultz
GenderFemale
SpecialityPsychiatry
Experience35 Years
Location6171 Childers Rd, Barboursville, West Virginia
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Debra Stultz attended and graduated from Jc Edwards School Of Medicine, Marshall University in 1989
  NPI Data:
  • NPI Number: 1346249836
  • Provider Enumeration Date: 07/18/2005
  • Last Update Date: 10/23/2015
  Medicare PECOS Information:
  • PECOS PAC ID: 5991821357
  • Enrollment ID: I20100923000578

Medical Identifiers

Medical identifiers for Debra Stultz such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1346249836NPI-NPPES
0115698000MedicaidWV
1346249836OtherHEALTHNET/TRICARE
134634936OtherMSBCBS
1346248936OtherMHNET
4510542OtherWVAETNA
1061788OtherCIGNA BEHAVIORAL HEALTH
271667227OtherCARELINK/COVENTRY
1346249836OtherUNITED BEHAVIORAL HEALTH
271667227Other4-MOST
3810018468MedicaidWV
1346249836OtherHUMANA
271667227OtherWELLS FARGO (PEIA)

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
2084P0800XPsychiatry & Neurology - Psychiatry 16672 (West Virginia)Primary
2084S0012XPsychiatry & Neurology - Sleep Medicine 16672 (West Virginia)Secondary

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Stultz Sleep Study Services, Pllc08403162044

News Archive

Tofacitinib drug shows promise against moderate-to-severe ulcerative colitis

An investigational drug currently under FDA review for the treatment of rheumatoid arthritis has now shown positive results in patients with moderate-to-severe ulcerative colitis, according to researchers at the University of California San Diego, School of Medicine.

Heat shock protein 90 helps explain the speed of evolution

Heat shock protein 90 (HSP90) has a greater impact on the appearance of new traits than previously expected, according to two articles published in the Proceedings of the National Academy of Science (PNAS) by researchers in Whitehead Member Susan Lindquist's lab and their colleagues in Christine Queitsch's lab at Harvard University's FAS Center for Systems Biology.

Continued political, financial support needed to reduce global malaria incidence

"With the globally agreed target of reversing the incidence rate of malaria by 2015 now in sight, top United Nations officials [on Thursday] urged the international community to stay committed to protecting people from this preventable disease and to scale up key interventions such as the provision of insecticide-treated mosquito nets," the U.N. News Centre reports, noting April 25 marked the annual World Malaria Day, with this year's theme, "Invest in the future. Defeat malaria."

Potentially flawed models may result in making inappropriate decisions on Covid-19 patients

Doctors may be making decisions about the care of Covid-19 patients based on weak and over-optimistic evidence, Keele researchers have found.

Alzheimer's drug pioneer to be awarded Israel Prize for Medicine

Israel's Minister of Education Shai Piron has announced that the Israel Prize for Medicine will be awarded to the Hebrew University of Jerusalem's Prof. Marta Weinstock-Rosin. A professor emeritus at the Hebrew University's School of Pharmacy-Institute for Drug Research in the Faculty of Medicine, Weinstock-Rosin is best known for developing Exelon, a blockbuster drug for the treatment of confusion and dementia related to Alzheimer's and Parkinson's diseases.

Read more Medical News

› Verified 2 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Debra Stultz allows following entities to bill medicare on her behalf.
Entity NameStultz Sleep Study Services, Pllc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1649593377
PECOS PAC ID: 0840316204
Enrollment ID: O20100923000513

News Archive

Tofacitinib drug shows promise against moderate-to-severe ulcerative colitis

An investigational drug currently under FDA review for the treatment of rheumatoid arthritis has now shown positive results in patients with moderate-to-severe ulcerative colitis, according to researchers at the University of California San Diego, School of Medicine.

Heat shock protein 90 helps explain the speed of evolution

Heat shock protein 90 (HSP90) has a greater impact on the appearance of new traits than previously expected, according to two articles published in the Proceedings of the National Academy of Science (PNAS) by researchers in Whitehead Member Susan Lindquist's lab and their colleagues in Christine Queitsch's lab at Harvard University's FAS Center for Systems Biology.

Continued political, financial support needed to reduce global malaria incidence

"With the globally agreed target of reversing the incidence rate of malaria by 2015 now in sight, top United Nations officials [on Thursday] urged the international community to stay committed to protecting people from this preventable disease and to scale up key interventions such as the provision of insecticide-treated mosquito nets," the U.N. News Centre reports, noting April 25 marked the annual World Malaria Day, with this year's theme, "Invest in the future. Defeat malaria."

Potentially flawed models may result in making inappropriate decisions on Covid-19 patients

Doctors may be making decisions about the care of Covid-19 patients based on weak and over-optimistic evidence, Keele researchers have found.

Alzheimer's drug pioneer to be awarded Israel Prize for Medicine

Israel's Minister of Education Shai Piron has announced that the Israel Prize for Medicine will be awarded to the Hebrew University of Jerusalem's Prof. Marta Weinstock-Rosin. A professor emeritus at the Hebrew University's School of Pharmacy-Institute for Drug Research in the Faculty of Medicine, Weinstock-Rosin is best known for developing Exelon, a blockbuster drug for the treatment of confusion and dementia related to Alzheimer's and Parkinson's diseases.

Read more Medical News

› Verified 2 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Debra Stultz is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Debra Stultz, MD
Po Box 457,
Barboursville, WV 25504-0457

Ph: (304) 733-5380
Debra Stultz, MD
6171 Childers Rd,
Barboursville, WV 25504-1227

Ph: (304) 733-5380

News Archive

Tofacitinib drug shows promise against moderate-to-severe ulcerative colitis

An investigational drug currently under FDA review for the treatment of rheumatoid arthritis has now shown positive results in patients with moderate-to-severe ulcerative colitis, according to researchers at the University of California San Diego, School of Medicine.

Heat shock protein 90 helps explain the speed of evolution

Heat shock protein 90 (HSP90) has a greater impact on the appearance of new traits than previously expected, according to two articles published in the Proceedings of the National Academy of Science (PNAS) by researchers in Whitehead Member Susan Lindquist's lab and their colleagues in Christine Queitsch's lab at Harvard University's FAS Center for Systems Biology.

Continued political, financial support needed to reduce global malaria incidence

"With the globally agreed target of reversing the incidence rate of malaria by 2015 now in sight, top United Nations officials [on Thursday] urged the international community to stay committed to protecting people from this preventable disease and to scale up key interventions such as the provision of insecticide-treated mosquito nets," the U.N. News Centre reports, noting April 25 marked the annual World Malaria Day, with this year's theme, "Invest in the future. Defeat malaria."

Potentially flawed models may result in making inappropriate decisions on Covid-19 patients

Doctors may be making decisions about the care of Covid-19 patients based on weak and over-optimistic evidence, Keele researchers have found.

Alzheimer's drug pioneer to be awarded Israel Prize for Medicine

Israel's Minister of Education Shai Piron has announced that the Israel Prize for Medicine will be awarded to the Hebrew University of Jerusalem's Prof. Marta Weinstock-Rosin. A professor emeritus at the Hebrew University's School of Pharmacy-Institute for Drug Research in the Faculty of Medicine, Weinstock-Rosin is best known for developing Exelon, a blockbuster drug for the treatment of confusion and dementia related to Alzheimer's and Parkinson's diseases.

Read more News

› Verified 2 days ago


Psychiatry & Neurology Doctors in Barboursville, WV

Phillip R Spangler, MD
Psychiatry & Neurology
Medicare: Accepting Medicare Assignments
Practice Location: 2 Chateau Ln, Barboursville, WV 25504
Phone: 304-736-9662    
Dr. David John Humphreys, MD
Psychiatry & Neurology
Medicare: Accepting Medicare Assignments
Practice Location: 3450 Us Route 60 E, Barboursville, WV 25504
Phone: 304-955-6300    Fax: 304-733-5903

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.